Aperture Bio Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Seed
- (In Progress)
- Investors
-
9
Aperture Bio General Information
Description
Developer of a preclinical oncology drug assessment platform designed to evaluate drug candidate performance and support treatment development decisions. The company offers proprietary spatial profiling technology that tracks drug responses in human three-dimensional tumor models over time, enabling biopharmaceutical companies to assess drug efficacy, optimize candidates, and make informed development decisions before clinical trials.
Contact Information
Website
www.aperture.bioCorporate Office
- Boston, MA
- United States
Corporate Office
- Boston, MA
- United States
Aperture Bio Timeline
Aperture Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Seed Round | In Progress | Product Development | ||||
| 7. Accelerator/Incubator | 16-Oct-2025 | Completed | Product Development | |||
| 6. Grant | 01-Jan-2025 | Completed | Product Development | |||
| 5. Seed Round | 03-Nov-2025 | Completed | Product Development | |||
| 4. Accelerator/Incubator | 18-Jul-2024 | Completed | Product Development | |||
| 3. Grant | 20-May-2024 | Completed | Product Development | |||
| 2. Accelerator/Incubator | 22-Aug-2023 | $270K | $295K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 24-May-2023 | $25K | $25K | Completed | Generating Revenue |
Aperture Bio Comparisons
Industry
Financing
Details
Aperture Bio Competitors (5)
One of Aperture Bio’s 5 competitors is Noetik, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Noetik | Venture Capital-Backed | San Francisco, CA | ||||
| Elephas | Venture Capital-Backed | Madison, WI | ||||
| Vivodyne | Venture Capital-Backed | Philadelphia, PA | ||||
| Stellaromics | Venture Capital-Backed | Boston, MA | ||||
| Xsphera Biosciences | Venture Capital-Backed | Cambridge, MA |
Aperture Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Aperture Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aperture Bio Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ACS BrightEdge | Corporate Venture Capital | Minority | ||
| Gurtin Ventures | Venture Capital | Minority | ||
| Endless Frontier Labs | Accelerator/Incubator | Minority | ||
| National Cancer Institute | Government | Minority | ||
| Creative Destruction Lab | Accelerator/Incubator |
Aperture Bio FAQs
-
When was Aperture Bio founded?
Aperture Bio was founded in 2022.
-
Where is Aperture Bio headquartered?
Aperture Bio is headquartered in Boston, MA.
-
What is the size of Aperture Bio?
Aperture Bio has 4 total employees.
-
What industry is Aperture Bio in?
Aperture Bio’s primary industry is Drug Discovery.
-
Is Aperture Bio a private or public company?
Aperture Bio is a Private company.
-
What is Aperture Bio’s current revenue?
The current revenue for Aperture Bio is .
-
How much funding has Aperture Bio raised over time?
Aperture Bio has raised $4.29M.
-
Who are Aperture Bio’s investors?
ACS BrightEdge, Gurtin Ventures, Endless Frontier Labs, National Cancer Institute, and Creative Destruction Lab are 5 of 9 investors who have invested in Aperture Bio.
-
Who are Aperture Bio’s competitors?
Noetik, Elephas, Vivodyne, Stellaromics, and Xsphera Biosciences are competitors of Aperture Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
